ArticleSignal transduction and targeted therapy2026

Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinoma.

Ugo Chianese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.